Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of infection due to Pneumocystis carinii.

× No keyword cloud information.

131 in total

1. Dihydropteroate synthase polymorphisms in Pneumocystis carinii.

Authors: B R Lane; J C Ast; P A Hossler; D P Mindell; M S Bartlett; J W Smith; S R Meshnick
Journal: J Infect Dis Date: 1997-02 Impact factor: 5.226

2. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Authors:
Journal: MMWR Recomm Rep Date: 1997-06-27

3. Discovery of selective, small-molecule inhibitors of RNA complexes--II. Self-splicing group I intron ribozyme.

Authors: H Y Mei; M Cui; S M Lemrow; A W Czarnik
Journal: Bioorg Med Chem Date: 1997-06 Impact factor: 3.641

4. Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.

Authors: A Plettenberg; U van Dyk; A Stoehr; H Albrecht; H J Stellbrink; J Berger; W Meigel
Journal: Dermatology Date: 1997 Impact factor: 5.366

5. Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia.

Authors: S Latouche; J L Poirot; C Bernard; P Roux
Journal: J Clin Microbiol Date: 1997-07 Impact factor: 5.948

6. Pulmonary nocardiosis in a patient with a bone marrow transplant. Bone Marrow Transplantation Team.

Authors: C Shearer; P H Chandrasekar
Journal: Bone Marrow Transplant Date: 1995-03 Impact factor: 5.483

7. Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.

Authors: C Hennequin; B Page; P Roux; C Legendre; H Kreis
Journal: Eur J Clin Microbiol Infect Dis Date: 1995-02 Impact factor: 3.267

8. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.

Authors: W T Hughes; S W LaFon; J D Scott; H Masur
Journal: J Infect Dis Date: 1995-05 Impact factor: 5.226

9. Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase.

Authors: I Ittarat; W Asawamahasakda; M S Bartlett; J W Smith; S R Meshnick
Journal: Antimicrob Agents Chemother Date: 1995-02 Impact factor: 5.191

10. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.

Authors: D Salmon-Ceron; A Fontbonne; J Saba; T May; F Raffi; C Chidiac; O Patey; J P Aboulker; D Schwartz; J L Vildé
Journal: J Infect Dis Date: 1995-09 Impact factor: 5.226

22 in total

Review 1. Antiparasitic agent atovaquone.

Authors: Aaron L Baggish; David R Hill
Journal: Antimicrob Agents Chemother Date: 2002-05 Impact factor: 5.191

Review 2. Treatment of infection due to Pneumocystis carinii.

Authors: J A Fishman
Journal: Antimicrob Agents Chemother Date: 1998-06 Impact factor: 5.191

3. 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation.

Authors: Emmanuel Montassier; Eric Batard; Sébastien Massart; Thomas Gastinne; Thomas Carton; Jocelyne Caillon; Sophie Le Fresne; Nathalie Caroff; Jean Benoit Hardouin; Philippe Moreau; Gilles Potel; Françoise Le Vacon; Marie France de La Cochetière
Journal: Microb Ecol Date: 2014-01-09 Impact factor: 4.552

4. Continuous axenic cultivation of Pneumocystis carinii.

Authors: S Merali; U Frevert; J H Williams; K Chin; R Bryan; A B Clarkson
Journal: Proc Natl Acad Sci U S A Date: 1999-03-02 Impact factor: 11.205

5. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Authors: Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij
Journal: Antimicrob Agents Chemother Date: 2002-10 Impact factor: 5.191

Review 6. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors: Martin Rodriguez; Jay A Fishman
Journal: Clin Microbiol Rev Date: 2004-10 Impact factor: 26.132

7. Antifungal activities and cytotoxicity studies of six new azasordarins.

Authors: E Herreros; M J Almela; S Lozano; F Gomez de las Heras; D Gargallo-Viola
Journal: Antimicrob Agents Chemother Date: 2001-11 Impact factor: 5.191

8. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.

Authors: Elena Jimenez; Antonio Martínez; El Moukhtar Aliouat; Jesus Caballero; Eduardo Dei-Cas; Domingo Gargallo-Viola
Journal: Antimicrob Agents Chemother Date: 2002-08 Impact factor: 5.191

9. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors: C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal: Emerg Infect Dis Date: 2000 May-Jun Impact factor: 6.883

Review 10. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Authors: Judith A Anesi; John W Baddley
Journal: Infect Dis Clin North Am Date: 2015-12-28 Impact factor: 5.982